Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03312556 · ClinicalTrials.gov registry record · NA
Treatment of Supine Hypertension in Autonomic Failure (CPAP)
A NA study of Autonomic Failure and Supine Hypertension, sponsored by Vanderbilt University Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT03312556: Recruiting NA study of Autonomic Failure and Supine Hypertension, sponsored by Vanderbilt University Medical Center.
NCT03312556 is a NA study of Autonomic Failure and Supine Hypertension that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 12 participants, below the 38-participant average among 11 other Autonomic Failure trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03312556, a NA study of Autonomic Failure and Supine Hypertension, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
Supine hypertension is a common problem that affects at least 50% of patients with primary autonomic failure. Supine hypertension can be severe and complicates the treatment of orthostatic hypotension. The purpose of this study is to assess whether continuous positive airway pressure (CPAP) decreases blood pressure in autonomic failure patients with supine hypertension.
Primary Outcome
change in supine systolic blood pressure from baseline
Conditions Studied
Interventions
- DRUG Placebo
- DEVICE continuous positive airway pressure (CPAP)
Study Locations (1)
Tennessee
- Autonomic Dysfunction Center/ Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2017-09-21 |
| Est. Completion | 2026-12-21 |
| Phase | NA |
What NCT03312556 shows while recruiting
NCT03312556 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 38-participant average among 11 other Autonomic Failure trials with a reported enrollment target (68% lower).
The record links to 2 conditions, with Autonomic Failure appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03312556 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT03312556 about?
NCT03312556 is a clinical study titled "Treatment of Supine Hypertension in Autonomic Failure (CPAP)". Supine hypertension is a common problem that affects at least 50% of patients with primary autonomic failure. Supine hypertension can be severe and complicates the treatment of orthostatic hypotension. The purpose of this study is to assess whether continuous positive airway pressure (CPAP) decrease...
What is the current status of trial NCT03312556?
This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2017-09-21. Estimated completion is 2026-12-21.
What conditions does trial NCT03312556 study?
This clinical trial studies the following conditions: Autonomic Failure, Supine Hypertension.
What interventions are being tested in trial NCT03312556?
The interventions under investigation include: Placebo (DRUG), continuous positive airway pressure (CPAP) (DEVICE).
Who is sponsoring clinical trial NCT03312556?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03312556 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autonomic Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03312556's enrollment target sits among peer trials
12 12th of 11 the lowest of 11 other Autonomic Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autonomic Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms
RECRUITING · NA
-
Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine Hypertension
RECRUITING · NA
-
Effect of Raised Head of the Bed on Lying Blood Pressure in Autonomic Failure
RECRUITING · NA
-
CPAP for the Treatment of Supine Hypertension
RECRUITING · NA
-
Abdominal Compression in Orthostatic Hypotension
COMPLETED · NA
-
Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI